Bookmark

Add to MyYahoo RSS

Emergent BioSolutions News

News on Emergent BioSolutions (Ticker: EBS) continually updated from thousands of sources around the net.

23 hrs ago | Reuters

German stocks - Factors to watch on August 20

The DAX top-30 index looked set to open unchanged on Wednesday, according to premarket data from brokerage Lang & Schwarz at 0613 GMT.

Comment?

Related Topix: Financial Markets, Biotech, Emergent Game Technologies

Tue Aug 19, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

This repur... )--Emergent BioSolutions Inc. and MorphoSys AG today announced an ag... )--Insert "Ross" in third paragraph, second sentence of release after "I urge Floridians to vote for Reps.

Comment?

Related Topix: Biotech, Emergent Game Technologies, Manufacturing, Valspar, Chemicals, Bank One, Banking, Financial Services

Benzinga

MorphoSys And Emergent BioSolutions Sign License Agreement to...

MorphoSys AG and Emergent BioSolutions Inc. today announced an agreement for the joint development and commercialization of ES414.

Comment?

Related Topix: Biotech, Emergent Game Technologies, Prostate Cancer, Health

GlobeNewswire

MorphoSys and Emergent BioSolutions Sign License Agreement to...

MARTINSRIED, Germany and MUNICH, Germany, Aug. 19, 2014 -- MorphoSys to Hold Public Conference Call on Wednesday, 20 August 2014, at 2:00pm CEST MorphoSys AG and Emergent BioSolutions Inc. today announced an agreement for the joint development and commercialization of ES414.

Comment?

Related Topix: Biotech, Emergent Game Technologies, World News, Germany, Prostate Cancer, Health

Customer Interaction Solutions

Emergent BioSolutions and MorphoSys Sign License Agreement to...

Emergent BioSolutions Inc. and MorphoSys AG today announced an agreement for the joint development and commercialization of Emergent's preclinical bi-specific antibody, ES414, targeting prostate cancer.

Comment?

Related Topix: Biotech, Emergent Game Technologies, Prostate Cancer, Health

Tue Aug 12, 2014

AmericanBankingNews.com

Emergent Biosolutions's "Neutral" Rating Reaffirmed at Zacks

's stock had its "neutral" rating restated by Zacks in a research report issued on Tuesday.

Comment?

Related Topix: Biotech, Emergent Game Technologies

Sat Aug 09, 2014

AlertNet

U.S. emergency labs ready to work on Ebola drugs if asked

All three U.S. facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any U.S. government effort to scale up a treatment for Ebola.

Comment?

Related Topix: Texas A&M Health Science Center, Biotech, Epidemic, Natural Disasters, Emergent Game Technologies, Medicine, Influenza, Health

Fri Aug 08, 2014

Pharmaceutical Processing

U.S. Government Exercises $18.9M Contract Option for Emergent...

Emergent BioSolutions announced today that the Centers for Disease Control and Prevention has exercised options under contract 200-2012-52242 for the supply of Vaccinia Immune Globulin Intravenous into the U.S. Strategic National Stockpile .

Comment?

Related Topix: Biotech, Emergent Game Technologies, Centers for Disease Control and Prevention, Food and Drug Administration, Cangene, Retail, Medicine, Cole National, Healthcare Industry

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Third Quarter Fiscal 2014 vs.... )--Harvard Apparatus Regenerative Technology reports operating results for 2Q 2014, including a sixth human tracheal transplant that was performed using its HART-Tra... )--St.

Comment?

Related Topix: Biotech, Emergent Game Technologies

Thu Aug 07, 2014

Seeking Alpha

Emergent BioSolutions (EBS) Q2 2014 Results - Earnings Call Webcast

The following audio is from a conference call that will begin on August 07, 2014 at 17:00 PM ET.

Comment?

Related Topix: Biotech, Emergent Game Technologies

Customer Interaction Solutions

Emergent BioSolutions Submits Biologics License Application to FDA...

Emergent BioSolutions Inc. today announced that it has submitted a Biologics License Application to the U.S. Food and Drug Administration for Anthrax Immune Globulin Intravenous [AIGIV] as part of a development contract with the Biomedical Advanced Research and Development Authority .

Comment?

Related Topix: Biotech, Emergent Game Technologies, Food and Drug Administration, Medicine, Immune Globulin (generic), Gammagard

Canada NewsWire

OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as ...

"John brings to our management team proven financial leadership and strategic corporate growth expertise that will be invaluable as we shape the future of OncoGenex," said , President and CEO of OncoGenex.

Comment?

Related Topix: Biotech, Medicine, SONUS Pharmaceuticals, OncoGenex Pharmaceuticals, Healthcare Industry, Emergent Game Technologies, Teva Pharmaceutical Industries

Tue Aug 05, 2014

WILX-TV Lansing

Waiting For An Ebola Vaccine

Susan joined News 10 as a reporter in April 2014. She is no stranger to the Midwest, having earned her Master of Science in Journalism from Northwestern University.

Comment?

Related Topix: Vaccinations, Health, Infectious Diseases, Medicine, Biotech, Emergent Game Technologies

Sat Jul 26, 2014

AmericanBankingNews.com

Emergent Biosolutions Rating Reiterated by Zacks

's stock had its "neutral" rating reaffirmed by Zacks in a report released on Friday.

Comment?

Related Topix: Biotech, Emergent Game Technologies

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••